XML 15 R7.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Cash flows from operating activities:    
Net income $ 44,904 $ 46,763
Adjustments to reconcile net income to net cash from operating activities:    
Depreciation 26,897 25,443
Amortization 7,681 8,660
Stock-based compensation expense 10,740 12,331
Provision for doubtful accounts 671 1,321
Deferred income taxes (5,119) (4,465)
Asset impairments 0 1,075
Gain on the sale of property, plant and equipment (7) (335)
Changes in operating assets and liabilities    
Accounts receivable 76,479 12,937
Contract assets (11,559) (6,472)
Inventories 102,540 1,789
Prepaid expenses and other assets (8,888) (14,433)
Accounts payable (16,107) (24,420)
Advance payments from customers (59,533) (8,879)
Accrued liabilities (28,127) (14,201)
Operating leases 1,192 830
Income taxes 1,545 (730)
Net cash provided by operating activities 143,309 37,214
Cash flows from investing activities:    
Additions to property, plant and equipment (22,555) (64,014)
Additions to capitalized purchased software (1,666) (2,699)
Proceeds from the disposal of property, plant and equipment 2,004 636
Other, net (1,521) (48)
Net cash used in investing activities (23,738) (66,125)
Cash flows from financing activities:    
Borrowings under credit agreement 455,000 614,500
Principal payments on credit agreement (507,461) (506,961)
Dividends paid (17,794) (17,570)
Employee taxes paid for with shares withheld (6,195) (5,804)
Proceeds from stock options exercised 482 68
Debt issuance costs 0 (216)
Principal payments on finance leases (135) (129)
Share repurchases (5,101) 0
Net cash (used in) provided by financing activities (81,204) 83,888
Effect of exchange rate changes on cash, cash equivalents and restricted cash 2,843 (1,647)
Net increase in cash, cash equivalents and restricted cash 41,210 53,330
Cash, cash equivalents and restricted cash at the beginning of the year 283,213 207,430
Cash, cash equivalents and restricted cash at the end of the period $ 324,423 $ 260,760